v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating Activities:        
Net loss $ (258,617) $ (211,173) $ (251,410) $ (179,579)
Adjustments to reconcile net loss to net cash (used) in / provided by operating activities:        
Common stock issued for consulting services - amortization 33,882    
Gain on change in warrant derivative (5,190)    
Non cash discount and interest expense on notes payable 69,035    
Changes in operating assets and liabilities:        
Trade accounts receivable 36,195 24,135 11,439
Inventories 29,549 9,599 (20,067)
Loan origination fee     (11,700)
Accounts payable and accrued expenses (37,891) 26,273 40,447 (947)
Advance deposits (13,357) 3,380 16,018 (2,661)
Sales taxes payable / (receivable) (991) 10,850 11,568 (9,145)
Net cash used in operating activities (147,385) (136,936) (192,005) (204,031)
Investing Activities:        
Net cash provided by investing activities
Financing Activities:        
Due to related party - CEO 23,000 12,512
Loans related parties 31,175 40,000 40,000
Short term loan payable     87,046
Line of credit 79,450 54,250 165,500
Note payable financing 118,500    
Net cash provided by financing activities 172,675 119,450 193,808 165,500
Net increase / (decrease) in cash 25,290 (17,486) 1,803 (38,531)
Cash, beginning of period 47,382 45,579 45,579 84,004
Cash, end of period 72,672 28,093 47,382 45,579
Supplemental disclosure of cash flow information        
Cash paid for interest 10,526 9,895 20,744 4,326
Cash paid for taxes
Non-cash Operating and Financing Activities:        
Issuance of common shares for services 117,500    
Right of use asset and operating lease $ 172,038